Importance & Scope:
Neurological disorders are diseases of the brain, spine and the nerves that connect them. There are more than 600 diseases of the nervous system, such as brain tumors, epilepsy, Parkinson's disease and stroke as well as less familiar ones such as front temporal dementia. Neuro-2015 aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results about all aspects of Neurology and their diseases. It also provides the chance for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the fields of Advertising and Marketing.
Neuro-2015 is housing the current research in Brain tumors which covers discussions including all tumors inside the cranium or in the central spinal canal. Neurological infections will focus on Neuropathology research into novel oncology treatments. Neuroradiology, Neurogenetics session revolves role of genetics in the development and function of the nervous system, Neuroimmunology, Cellular Neuroscience and more. Neuro-2015 also provides an exclusive environment to the students for their development of research and gives them an opportunity to raise the profile of their research by poster presentations. We bring together business, creative, and technology leaders from the advertising, marketing, and media industry for the most current and relevant.
Figure 1:Represents the Percentage of people suffering with neurological disorder globally
Why Rome?
Europeans are plagued by mental and neurological illnesses, with almost 165 million people or 38 percent of the population suffering each year, mental illnesses cause a huge economic and social burden measured in the hundreds of billions of Euros.
In Italy, the prevalence of chronic pain, according to the latest estimates, is equal to 27%. There is a lack of accurate data on neuropathic pain in Italy
In Italy, there are approximately 200,000 new cases of stroke each year. Approximately 500,000 Italians suffer from epilepsy, of which 125,000 have treatment resistant forms. Multiple sclerosis is one of the most frequent causes of disability in young people. The age of onset can vary from 15 to 50 years of age. The group of rare neurodegenerative and neurological diseases includes a vast number of slowly-evolving neurological illnesses, often of genetic origin and characterized by a progressive degeneration of the neuronal and axonal systems, with an increase in the cells killed by apoptosis, which involves all cell systems.
The CONFERENCE on neurology and therapeutics is intended to provide a medium for the communication of results and ideas in the field of neuroscience. The CONFERENCE welcomes contributions in both the basic and clinical aspects of the neurosciences and special sections on the Health Care and Neurological Digressions a forum for cultural topics related to the neurosciences.
Conference Highlights:
- Spinal Disorders
- Cerebrovascular Disease
- Interventional Neurology
- Neuro Infections
- Neuro-Oncology
- Neuro Immunology
- Neurological Disorders
- Neuromuscular Disease
- Dementia & Aging
- Headache & Pain
- Neuro Rehabilitation and comprehensive care
- Neuro critical Care
- Case Studies and Clinical Trials
Why to attend???
Remedial approach into the Neurological Disorders and new clinical practices With members from around the world focused on learning about novel therapies in neurology, this is your single best opportunity to reach the largest assemblage of participants from the ADHD community. Conduct demonstrations, distribute information, meet with current and potential customers, make a splash with a new clinical trails, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Neurology fields are hallmarks of this conference.
A Unique Opportunity for Advertisers and Sponsors at this International event: (strong)
Major Neurological Associations around the Globe
American Academy of Neurology
European Neurological Societies
World Federation of Neurology
Spanish Society of Neurology
Major Neurological Associations in Italy
Hilarescere Foundation in Italy
Italian MS society in Italy
Southern Clinical Neurological Society
ESNR European Society of Neuroradiology
Vision sciences society
Statistical Analysis of Associations
Figure 2: Statistical Analysis
Target Audience:
The target audience for this conference is neurologists and specialists in related fields such as internal medicine, pediatrics, rehabilitation medicine and psychiatry. Health care professionals from all backgrounds involved in the diagnosis and management of neurological disease (nurses, nurse practitioners, physician assistants, physical/occupational therapists, athletic trainers, optometrists).
Target Audience:
Neurologist 50%
Academia 30%
Others 20%
Figure 3: Target Audience
Top Universities in Italy:
University of Trento
University of Milan
University of Naples Federico II
Tor Vergata University of Rome
University of Pisa
Figure 4: Top Universities
Companies Associated with Neurology
Figure 5:Companies Associated with Advertising and Marketing
Glance at Market of Neurology:
The World Health Organization (WHO) shows that 6.8 million people die every year as a result of neurological disorders, in Europe the economic cost of neurological diseases was estimated at about 139 billion euros in 2004. Total European 2010 cost of brain disorders was €798 billion and will grow to $480 billion by 2030
The European average cost per person with a disorder of the brain ranged between €285 for headache and €30 000 for neuromuscular disorders. Total annual cost per disorder (in billion € 2010) was as follows: addiction 65.7; anxiety disorders 74.4; brain tumor 5.2; child/adolescent disorders 21.3; dementia 105.2; eating disorders 0.8; epilepsy 13.8; headache 43.5; mental retardation 43.3; mood disorders 113.4; multiple sclerosis 14.6; neuromuscular disorders 7.7; Parkinson's disease 13.9; personality disorders 27.3; psychotic disorders 93.9; sleep disorders 35.4; somatoform disorder 21.2; stroke 64.1; and traumatic brain injury 33.0..
This covers an in-depth analysis and an estimation of the global neurology devices market, for the period of 2013 - 2029, considering 2012 as the base year for calculations. In addition, the current market dynamics including the drivers, restraints, trends and recent developments have been captured throughout the report. The neurology devices market has been further segmented into CSF management devices, interventional neurology, neurosurgery and neurostimulation devices markets.
Figure 6: Medicines in Development for Neurological Disorders By Disease
Market Growth of Neurology
Statistics which shows Market Growth for Neurological researchers in upcoming 15 years
Figure 7: Global Neurological diseases Growth Forecast
Figure 8: Individual neurological disorders as percentage of total neurological disorders
Statistics of Marketers, Researchers and Academicians working on Neurology:
Figure 9: People
Figure 10: Individual neurological disorders as percentage of total neurological disorders
References:
- http://www.fiercepharma.com/sermosurveys/contributions-neurology-healthcare-companies-and-products-oct-19-2011
- http://www.who.int/mental_health/neurology/neurological_disorders_report_web.pdf
- http://www.who.int/mediacentre/news/releases/2007/pr04/en/
- http://www.fiercepharma.com/sermosurveys/contributions-neurology-healthcare-companies-and-products-oct-19-2011
|
